NUI Galway patient care projects receive €1.8m backing
2 May 2017 | 0
Three patient care research projects are to begin at NUI Galway, with the support of the Health Research Board, have secured a total of €1.8 million in funding.
Dr Martin O’Donnell, Professor of Translational Medicine at NUI Galway has been funded under the definitive interventions and feasibility award programme for research on community risk-based monitoring for an atrial fibrillation trial. Atrial fibrillation is an irregular and often rapid heart rate that can increase the risk of stroke, heart failure and other heart-related complications.
Professor of Diabetic Medicine Prof Sean Dinneen secured a definitive intervention and feasibility award for research aimed at improving outcomes for young adults living with type 1 diabetes. The study team based across the NUI Galway and Galway University Hospital campuses will work with national and international collaborators including a public and patient involvement panel (consisting of 10 young adult service users living with type 1 diabetes) to test and pilot the feasibility of a new intervention, called D1 Now.
Prof Eamon O’Shea, Director of the Centre for Economic & Social Research on Dementia, received an applied partnership award for resource allocation, priority-setting and consensus in dementia care in Ireland. The aim of this study is to address key questions regarding optimal service and support mix for people with dementia and to facilitate a more efficient and equitable resource allocation process that includes the delivery of personalised, community-based supports for people with dementia. Prof O’Shea will be working with the National Dementia Office through the Health Service Executive to develop Dementia care plans to address optimal resource allocation for different dementia case types.
The Definitive Intervention & Feasibility Award scheme is designed to boost research activity in clinical trials and interventions, whereas the Applied Partnership Award scheme aims to encourage a partnership-based, co-funding approach to nationally relevant research topics.
Dr Mairead O’Driscoll, interim chief executive at the Health Research Board, said: “Findings from these projects have the potential to make a big impact on patient care and patient outcomes, in a relatively short space of time. Through these awards, the HRB is delivering on two key goals in our strategy. Firstly, to boost clinical trial activity in Ireland and secondly, to encourage partner driven research that addresses research questions which are directly relevant to the needs of our health service.”